Skip to content
← Back to this collection

PUBLICATIONS · 21335443

NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Natl Compr Canc Netw
Publication date
2011 Feb
First author
O'Brien S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      O'Brien S
      type
      Author
    2. name
      Berman E
      type
      Author
    3. name
      Moore JO
      type
      Author
    4. name
      Pinilla-Ibarz J
      type
      Author
    5. name
      Radich JP
      type
      Author
    6. name
      Shami PJ
      type
      Author
    7. name
      Smith BD
      type
      Author
    8. name
      Snyder DS
      type
      Author
    9. name
      Sundar HM
      type
      Author
    10. name
      Talpaz M
      type
      Author
    11. name
      Wetzler M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      O'Brien S
      type
      Author
    2. name
      Berman E
      type
      Author
    3. name
      Moore JO
      type
      Author
    4. name
      Pinilla-Ibarz J
      type
      Author
    5. name
      Radich JP
      type
      Author
    6. name
      Shami PJ
      type
      Author
    7. name
      Smith BD
      type
      Author
    8. name
      Snyder DS
      type
      Author
    9. name
      Sundar HM
      type
      Author
    10. name
      Talpaz M
      type
      Author
    11. name
      Wetzler M
      type
      Author
    bibliography ids
    1. nci-bib-c7a9518b3c64997eb1f0d10a
    book metadata
    content sha256
    51c28c4dca634b0ceaf6acdeaaa4022ad5aeca9c67734387a6a2d31ce7575a26
    document type
    citation
    dois
    1. 10.6004/jnccn.2011.0125
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21335443
    immutable id
    pubmed:21335443@51c28c4dca634b0ceaf6acdeaaa4022ad5aeca9c67734387a6a2d31ce7575a26
    journal
    abbreviation
    J Natl Compr Canc Netw
    issn electronic
    1540-1413
    issn print
    1540-1405
    issue
    0 2
    name
    Journal of the National Comprehensive Cancer Network : JNCCN
    nlm unique id
    101162515
    pages
    S1-25
    volume
    9 Suppl 2
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21335443
      provenance
      batch id
      edef4b7f1a2a505cd5a9
      provider
      NCBI PubMed ESummary
      record sha256
      7c7dd2abb66e2c7c39d79ddb2308a489dbb154b5ba57d5ee5b3021204c8a14a3
      response sha256
      d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
      retrieved at
      2026-09-09T23:46:38.027615+00:00
      publication date
      display
      2011 Feb
      precision
      month
      year
      2011
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21335443/
      title
      NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.

      Preserved source evidence · Not medical advice